fbpx

Breast Cancer

Metastatic Left Breast Carcinoma

Female, 55 years

Patient Internal 103583331

ICD-10 code

C50.5 Malignant Neoplasm of Lower Outer Quadrant of Breast

Diagnosis (Incl. Metastases/Stage) and Year

March 2015
Malignant Neoplasm of the Lower Outer Quadrant of the Breast. Carcinoma of the Left Breast
pT2pN0(sn)cM0 G3 LVI, IIA st., ER(-), PR(-), HER2(-), Ki67 – 60 %. 2019 – Metastasis to the Lungs. 2021 –
Metastasis to the Brain.

Previous Treatment

Surgery, Chemotherapy (Paclitaxel/Gemcitabine), Radiation Therapy, Target Therapy (Olaparib).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of 13,3 months.

Treatment Provided

Autologous DCV (4 doses) and CIK (4 doses) over a period of 5 months.

Patient Survival/Condition and Year
Date of Review: 15/10/2023

Patient is alive, with stable disease and has survived 54 months after detection of Metastasis (progression). It can be concluded that the addition of Immunotherapy, alongside Surgery, Chemotherapies and Radiation Therapy, has benefited the patient with disease control and has greatly extended her lifespan.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.